Biased exon/intron distribution of cryptic and de novo 3′ splice sites
暂无分享,去创建一个
J. Královičová | I. Vořechovský | M. Christensen | Jana Královičová | Mikkel B. Christensen | Igor Vořechovský
[1] L. Ala‐Kokko,et al. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations. , 1998, American journal of human genetics.
[2] M. Vidaud,et al. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. , 1992, Genomics.
[3] G. Ast,et al. Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. , 2005, Human molecular genetics.
[4] J. Trapman,et al. Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. , 1997, American journal of human genetics.
[5] K. Mayer,et al. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. , 2000, Biochimica et biophysica acta.
[6] S. Ghosh,et al. A novel intronic mutation results in the use of a cryptic splice acceptor site within the coding region of UGT1A1, causing Crigler-Najjar syndrome type 1. , 2002, Molecular genetics and metabolism.
[7] D. Prockop,et al. A-2-->G transition at the 3' acceptor splice site of IVS17 characterizes the COL2A1 gene mutation in the original Stickler syndrome kindred. , 1996, American journal of medical genetics.
[8] M. Hentze,et al. Abnormally spliced b-globin mRNAs : a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay , 2002 .
[9] W. Engel,et al. Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndrome , 1999, Journal of medical genetics.
[10] T. Dryja,et al. Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with Retinitis pigmentosa , 1998, Nature Genetics.
[11] J. Valcárcel,et al. Dual Function for U2AF35 in AG-Dependent Pre-mRNA Splicing , 2001, Molecular and Cellular Biology.
[12] W. Fenton,et al. Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency. , 1991, American journal of human genetics.
[13] R. Flavell,et al. β + Thalassemia: Aberrant splicing results from a single point mutation in an intron , 1981, Cell.
[14] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[15] O. Blumenfeld,et al. Alternative splicing of a novel glycophorin allele GPHe(GL) generates two protein isoforms in the human erythrocyte membrane. , 1997, Blood.
[16] J. Beggs,et al. Extensive interactions of PRP8 protein with the 5′ and 3′ splice sites during splicing suggest a role in stabilization of exon alignment by U5 snRNA. , 1995, The EMBO journal.
[17] J. G. Patton,et al. Functional analysis of the polypyrimidine tract in pre-mRNA splicing. , 1997, Nucleic acids research.
[18] W. Kuo,et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. , 1994, Science.
[19] H. Rabb,et al. Genetic cause of leukocyte adhesion molecule deficiency. Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta 2 integrins. , 1992, The Journal of biological chemistry.
[20] J. Laporte,et al. Confirmation of prenatal diagnosis results of X‐linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene , 1998, Human mutation.
[21] J. Varley,et al. Characterization of germline TP53 splicing mutations and their genetic and functional analysis , 2001, Oncogene.
[22] C. Heizmann,et al. Identification of mutations causing 6‐pyruvoyl‐tetrahydropterin synthase deficiency in four Italian families , 1997, Human mutation.
[23] P. A. Biro,et al. Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Bouck,et al. Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract , 1995, Molecular and cellular biology.
[25] R. Spritz,et al. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2). , 1995, American journal of human genetics.
[26] F. Baralle,et al. Genetic studies on myeloperoxidase deficiency in Italy. , 2004, Japanese journal of infectious diseases.
[27] R. Wevers,et al. A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder , 2000, Annals of human genetics.
[28] I. Vauhkonen,et al. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland , 2002, Journal of Molecular Medicine.
[29] T. Funahashi,et al. A novel point mutation in a splice acceptor site of intron 1 of the human low density lipoprotein receptor gene which causes severe hypercholesterolemia: An unexpected absence of exon skipping , 1998, Human mutation.
[30] B. Coller,et al. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Pérez-Cerdá,et al. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene. , 2001, Molecular genetics and metabolism.
[32] W. Cole,et al. COL5A1 Exon 14 Splice Acceptor Mutation Causes a Functional Null Allele, Haploinsufficiency of α1(V) and Abnormal Heterotypic Interstitial Fibrils in Ehlers-Danlos Syndrome II* , 2001, The Journal of Biological Chemistry.
[33] Christopher W. J. Smith,et al. Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns , 1993, Molecular and cellular biology.
[34] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[35] G. Deuschl,et al. Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion , 1997, Neurogenetics.
[36] C. Burant,et al. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. , 1998, The Journal of clinical investigation.
[37] C. Patrosso,et al. Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Hennet,et al. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) , 2004, Journal of Medical Genetics.
[39] J. Vandesompele,et al. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene , 2002, Oncogene.
[40] M. Claustres,et al. Point mutations in the dystrophin gene: Evidence for frequent use of cryptic splice sites as a result of splicing defects , 1999, Human mutation.
[41] C. Mathew,et al. High frequency of large intragenic deletions in the Fanconi anemia group A gene. , 1999, American journal of human genetics.
[42] W. Cole,et al. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. , 1992, The Journal of biological chemistry.
[43] F. Collins,et al. Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron. , 1986, The EMBO journal.
[44] C. Schwartz,et al. Multiple exon screening using restriction endonuclease fingerprinting (REF): Detection of six novel mutations in the L1 cell adhesion molecule (L1CAM) gene , 1998, Human mutation.
[45] G. Pavlakis,et al. The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. , 1987, The Journal of biological chemistry.
[46] C. Glover,et al. Gene expression profiling for hematopoietic cell culture , 2006 .
[47] I. Tsukimoto,et al. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency. , 1997, Blood.
[48] Y. Yazaki,et al. Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome. , 1998, The Journal of clinical investigation.
[49] Peter G. Korning,et al. Splice Site Prediction in Arabidopsis Thaliana Pre-mRNA by Combining Local and Global Sequence Information , 1996 .
[50] J. Fraumeni,et al. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome , 2000, Oncogene.
[51] Zhenhua Zhang,et al. Distinct mechanisms lead to HPRT gene mutations in leukemic cells , 2004, Genes, chromosomes & cancer.
[52] M. Mannens,et al. The Human Chitotriosidase Gene NATURE OF INHERITED ENZYME DEFICIENCY* , 1998 .
[53] F. Kramer,et al. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. , 2004, Cancer genetics and cytogenetics.
[54] J. Minna,et al. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.
[55] R. Reed,et al. An Upstream AG Determines Whether a Downstream AG Is Selected during Catalytic Step II of Splicing , 2001, Molecular and Cellular Biology.
[56] P. Mannucci,et al. Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia. , 2004, Blood.
[57] I. Vořechovský,et al. Identification of Splicing Silencers and Enhancers in Sense Alus: a Role for Pseudoacceptors in Splice Site Repression , 2005, Molecular and Cellular Biology.
[58] R. Guigó,et al. Are splicing mutations the most frequent cause of hereditary disease? , 2005, FEBS letters.
[59] R. Weinshilboum,et al. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. , 1998, The Journal of clinical investigation.
[60] M. Dyer,et al. Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.
[61] S. Thibodeau,et al. Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts , 1999, Human Genetics.
[62] R. Reed,et al. Evidence that U5 snRNP recognizes the 3′ splice site for catalytic step II in mammals , 1997, The EMBO journal.
[63] B. Dworniczak,et al. Identification of four novel mutations in the factor VIII gene: Three missense mutations (E1875G, G2088S, I2185T) and a 2‐bp deletion (1780delTC) , 1998, Human mutation.
[64] P. Huppke,et al. Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions , 2001, Human mutation.
[65] E. M. McCarthy,et al. Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. , 1998, Human molecular genetics.
[66] S. Berget. Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.
[67] V. Bataille,et al. Gorlin syndrome: Identification of 4 novel germ‐line mutations of the human patched (PTCH) gene , 1998, Human mutation.
[68] A. V. D. Eb,et al. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome , 1990, Cell.
[69] K. Nakai,et al. Construction of a novel database containing aberrant splicing mutations of mammalian genes. , 1994, Gene.
[70] M. Morita,et al. A novel mutation in the spastin gene in a family with spastic paraplegia , 2002, Neuroscience Letters.
[71] A. Ruvinsky,et al. Natural Selection Affects Frequencies of AG and GT Dinucleotides at the 5′ and 3′ Ends of Exons , 2004, Genetics.
[72] E. Lyon,et al. Implications of a novel cryptic splice site in the BRCA1 gene. , 1998, American journal of medical genetics.
[73] Ludwine Messiaen,et al. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 , 2003, Genes, chromosomes & cancer.
[74] I. Mattaj,et al. The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. , 2000, Genes & development.
[75] C. Bodemer,et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.
[76] F. Morel,et al. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A220) leading to the activation of a cryptic splice site in intron 4 , 2002, Human Genetics.
[77] E. Vafiadaki,et al. Mutation analysis in 57 unrelated patients with MPS II (Hunter’s disease) , 1998, Archives of disease in childhood.
[78] M. Hentze,et al. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. , 2002, Blood.
[79] Y. Fujii‐Kuriyama,et al. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Nicklas,et al. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. , 1998, Mutation research.
[81] Ravinder Singh,et al. Sex lethal and U2 small nuclear ribonucleoprotein auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding. , 2003, RNA.
[82] G. Zambruno,et al. Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition. , 2001, The Journal of investigative dermatology.
[83] R. Krug,et al. Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes , 1992, Molecular and cellular biology.
[84] S. Dimauro,et al. Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. , 1994, American journal of human genetics.
[85] T. Hansen,et al. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young , 2002, Diabetologia.
[86] D. Quon,et al. Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase. , 1990, The Journal of biological chemistry.
[87] H. Mandel,et al. Profound biotinidase deficiency caused by a point mutation that creates a downstream cryptic 3' splice acceptor site within an exon of the human biotinidase gene. , 1997, Human molecular genetics.
[88] Y. Takeshima,et al. Heterogous Dystrophin mRNA Produced by a Novel Splice Acceptor Site Mutation in Intermediate Dystrophinopathy , 2003, Pediatric Research.
[89] Jouni Uitto,et al. Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. , 1999, Human molecular genetics.
[90] M. Green,et al. Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. , 1999, Genes & development.
[91] T. Nakano,et al. Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. , 1989, The Journal of biological chemistry.
[92] J. Barton,et al. Hemojuvelin (HJV) mutations in persons of European, African‐American and Asian ancestry with adult onset haemochromatosis , 2004, British journal of haematology.
[93] 中村 こず枝. A novel single-base substitution(380C>T)that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene , 2002 .
[94] H. Scheffer,et al. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. , 1996, The Journal of investigative dermatology.
[95] M. Macek,et al. Human β-Mannosidase cDNA Characterization and First Identification of a Mutation Associated with Human β-Mannosidosis , 1998 .
[96] A. Tanae,et al. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. , 1995, American journal of human genetics.
[97] J. Zschocke,et al. Phenylketonuria mutations in Germany , 1999, Human Genetics.
[98] D. Cooper,et al. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.
[99] H. Steingrimsdottir,et al. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. , 1992, Nucleic acids research.
[100] F. D. de Rooij,et al. Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update , 1999, Human mutation.
[101] P. Nürnberg,et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.
[102] Richard J. Thompson,et al. A novel spice–site mutation in the γ subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families , 1996, Nature Genetics.
[103] M. Moore,et al. Evidence for a linear search in bimolecular 3' splice site AG selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[104] S. Tonstad,et al. Mutant transcripts of the LDL receptor gene: mRNA structure and quantity , 1999, Human mutation.
[105] A. Tates,et al. Molecular analysis of mutations affecting hprt mRNA splicing in human T‐lymphocytes in vivo , 1992, Environmental and molecular mutagenesis.
[106] L. Kalaydjieva,et al. Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for phenylketonuria in parts of southern Europe. , 1991, Genomics.
[107] G Mortier,et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.
[108] X. Estivill,et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.
[109] R. Reed,et al. The RNA splicing factor hSlu7 is required for correct 3′ splice-site choice , 1999, Nature.
[110] N L Harris,et al. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. , 1990, Methods in enzymology.
[111] J. Beggs,et al. snRNA interactions at 5' and 3' splice sites monitored by photoactivated crosslinking in yeast spliceosomes. , 1995, RNA.
[112] G. Tromp,et al. Single base mutation in the pro alpha 2(I) collagen gene that causes efficient splicing of RNA from exon 27 to exon 29 and synthesis of a shortened but in-frame pro alpha 2(I) chain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[113] S. Weissman,et al. Abnormally spliced messenger RNA in erythroid cells from patients with β + thalassemia and monkey cells expressing a cloned β +-thalassemic gene , 1982, Cell.
[114] R. Hennekam,et al. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.
[115] André Rosenthal,et al. Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X–linked hydrocephalus , 1992, Nature Genetics.
[116] X. Zhang,et al. Functional and physical interaction between the yeast splicing factors Slu7 and Prp18. , 1997, Nucleic acids research.
[117] M. Macek,et al. Human beta-mannosidase cDNA characterization and first identification of a mutation associated with human beta-mannosidosis. , 1998, Human molecular genetics.
[118] Eight new mutations of the phenylalanine hydroxylase gene in Italian patients with hyperphenylalaninemia , 1998, Human mutation.
[119] Adrian R. Krainer,et al. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites , 1990, Cell.
[120] J. Valcárcel,et al. Splicing Regulation at the Second Catalytic Step by Sex-lethal Involves 3′ Splice Site Recognition by SPF45 , 2002, Cell.
[121] B. Lorenz,et al. Tubby-like protein-1 mutations in autosomal recessive retinitis pigmentosa , 1998, The Lancet.
[122] M. Jonkman,et al. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen , 2004, The British journal of dermatology.
[123] P. Czernichow,et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. , 2001, American journal of human genetics.
[124] Z. Tsuchihashi,et al. Mutation and haplotype analyses of the Werner’s syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population , 1997, Human Genetics.
[125] D. Horn,et al. Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome. , 2004, American journal of human genetics.
[126] Gene W. Yeo,et al. Variation in sequence and organization of splicing regulatory elements in vertebrate genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[127] A. Krainer,et al. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[128] M. Krempf,et al. Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia , 2002, Human Genetics.
[129] Gene W. Yeo,et al. Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.
[130] D. Farber,et al. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene. , 1998, Investigative ophthalmology & visual science.
[131] J. Brunzell,et al. A novel A-->G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. , 1996, Journal of lipid research.
[132] K. Tanaka,et al. Characterization of a splicing mutation in group A xeroderma pigmentosum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[133] Stephen M. Mount,et al. A catalogue of splice junction sequences. , 1982, Nucleic acids research.
[134] R. Gibbs,et al. Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[135] Ravi Sachidanandam,et al. Intrinsic differences between authentic and cryptic 5' splice sites. , 2003, Nucleic acids research.
[136] P. Byers,et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. , 2002, American journal of human genetics.
[137] P. Sharp,et al. Splicing of precursors to mRNAs by the spliceosomes , 1993 .
[138] S E Antonarakis,et al. beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[139] F. Muntoni,et al. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. , 1998, Neuromuscular disorders : NMD.
[140] H. Horvitz,et al. Identification of three novel mutations in the gene for Cu Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis , 1995, Neuromuscular Disorders.
[141] J. Alonso,et al. Identification of 26 new constitutional RB1 gene mutations in Spanish, Colombian, and Cuban retinoblastoma patients , 2005, Human mutation.
[142] R. Amann,et al. Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .
[143] X. Estivill,et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.
[144] T. Miyawaki,et al. A 3′ splice site consensus sequence mutation in the intron 3 of the α-galactosidase a gene in a patient with Fabry disease , 1991, Japanese Journal of Human Genetics.
[145] S. Tsuji,et al. A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection. , 1992, The Journal of biological chemistry.
[146] J. Hardy,et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. , 1999, Human molecular genetics.
[147] J. Uitto,et al. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa. , 1998, The Journal of investigative dermatology.
[148] J. D. den Dunnen,et al. Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD. , 1996, Journal of medical genetics.
[149] W. Lissens,et al. Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation. , 1994, Blood.
[150] A. Toubert,et al. A novel HLA-B*39 allele (HLA-B*3916) due to a rare mutation causing cryptic splice site activation. , 2000, Human immunology.
[151] J. Tolmie,et al. The molecular basis of malonyl-CoA decarboxylase deficiency. , 1999, American journal of human genetics.
[152] H. Pollmann,et al. Mutational analysis of ectopic factor VIII transcripts from hemophilia A patients: identification of cryptic splice site, exon skipping and novel point mutations , 1997, Human Genetics.
[153] A. Krainer,et al. Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.
[154] C. H. Gross,et al. Prp22, a DExH‐box RNA helicase, plays two distinct roles in yeast pre‐mRNA splicing , 1998, The EMBO journal.
[155] Rolf Backofen,et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.
[156] M. Amaral,et al. Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane , 1999, Human mutation.
[157] H. Osaka,et al. Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online. , 1998, Human mutation.
[158] C. Shoulders,et al. Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. , 1996, Human molecular genetics.
[159] P. Sharp,et al. Three recognition events at the branch‐site adenine. , 1996, The EMBO journal.
[160] J. G. Patton,et al. Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns , 1989, Nature.
[161] K Rohrschneider,et al. The 2588G-->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease. , 1999, American journal of human genetics.
[162] A. Beaudet,et al. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. , 1990, The Journal of biological chemistry.
[163] M. Tanner,et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. , 2002, Blood.
[164] M. Hou,et al. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan , 1999, Human Genetics.
[165] B. Séraphin,et al. The role of branchpoint‐3′ splice site spacing and interaction between intron terminal nucleotides in 3′ splice site selection in Saccharomyces cerevisiae , 1997, The EMBO journal.
[166] Sara G. Becker-Catania,et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.
[167] F. Muntoni,et al. Laminin α2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy , 1998, Neuromuscular Disorders.
[168] P. Bosma,et al. Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1. , 1998, American journal of human genetics.
[169] R. Gibbs,et al. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. , 1990, Genomics.
[170] J. Gécz,et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.
[171] G. Isshiki,et al. Two mutations remote from an exon/intron junction in the β-hexosaminidase β-subunit gene affect 3’-splice site selection and cause Sandhoff disease , 1998, Human Genetics.
[172] T. Dryja,et al. Evaluation of the human arrestin gene in patients with retinitis pigmentosa and stationary night blindness. , 1998, Investigative ophthalmology & visual science.
[173] D. Evans,et al. A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier. , 1998, British Journal of Cancer.
[174] J. Královičová,et al. Branch site haplotypes that control alternative splicing. , 2004, Human molecular genetics.
[175] T. Gilliam,et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.
[176] D. Kastner,et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. , 2001, American journal of human genetics.
[177] Y. Eto,et al. Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing , 1994, Human Genetics.
[178] J. Genest,et al. Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]. , 1999, Atherosclerosis.
[179] F. Pociot,et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. , 2005, American journal of human genetics.
[180] T. Lerner,et al. Spectrum of mutations in the Batten disease gene, CLN3. , 1997, American journal of human genetics.
[181] C. W. Fisher,et al. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34. , 1991, Biochemical and biophysical research communications.
[182] L. Chasin,et al. Computational definition of sequence motifs governing constitutive exon splicing. , 2004, Genes & development.
[183] C. Wadelius,et al. New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. , 1995, American journal of human genetics.
[184] J. Tam,et al. A novel function for the U2AF 65 splicing factor in promoting pre‐mRNA 3′‐end processing , 2002, EMBO reports.